Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 7-((3r)-aminohexahydro-1h-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
2. 7-(3-aminohexahydro-1h-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
3. Besifloxacin
4. Besivance
5. Bol-303224-a
1. Besifloxacin Hcl
2. 405165-61-9
3. Besivance
4. Besifloxacin (hydrochloride)
5. Bol-303224-a
6. Besifloxacin Hydrochloride [usan]
7. Ss734
8. Besifloxacin Hcl (besivance)
9. Besifloxacin (as Hydrochloride)
10. Ss-734
11. 7506a6j57t
12. 405165-61-9 (hcl)
13. Unii-7506a6j57t
14. Besifloxacin Hydrochloride (usan)
15. (+)-7-((3r)-3-aminohexahydro-1h-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
16. (+)-7-[(3r)-3-aminohexahydro-1h-azepin-1-yl]-8-chloro-1- Cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride.
17. (r)-7-(3-aminoazepan-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
18. 3-quinolinecarboxylic Acid, 7-((3r)-3-aminohexahydro-1h-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, Monohydrochloride
19. 7-[(3r)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic Acid;hydrochloride
20. Bol 303224a
21. Besivance (tn)
22. Besivance Hydrochloride
23. 7-[(3r)-3-aminohexahydro-1h-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Hydrochloride
24. Schembl291598
25. Chembl1201761
26. Dtxsid20193529
27. Besifloxacin Hydrochloride- Bio-x
28. Amy18155
29. Ex-a1339
30. Mfcd14636632
31. S3055
32. Akos025401618
33. Besifloxacin Hydrochloride [mi]
34. Ccg-221259
35. Cs-0713
36. Ac-23367
37. Bb164241
38. Besifloxacin Hydrochloride [mart.]
39. Besifloxacin Hydrochloride [vandf]
40. Hy-17028
41. Besifloxacin Hydrochloride [who-dd]
42. Besifloxacin Hydrochloride [orange Book]
43. C75052
44. D08872
45. 165b619
46. A848253
47. J-519840
48. Q27266315
49. Besifloxacin Hydrochloride 100 Microg/ml In Acetonitrile:water
50. (r)-7-(3-aminohexahydro-1h-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Hydrochloride
Molecular Weight | 430.3 g/mol |
---|---|
Molecular Formula | C19H22Cl2FN3O3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 429.1022251 g/mol |
Monoisotopic Mass | 429.1022251 g/mol |
Topological Polar Surface Area | 86.9 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 656 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Besifloxacin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Besifloxacin Hydrochloride, including repackagers and relabelers. The FDA regulates Besifloxacin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Besifloxacin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Besifloxacin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Besifloxacin Hydrochloride supplier is an individual or a company that provides Besifloxacin Hydrochloride active pharmaceutical ingredient (API) or Besifloxacin Hydrochloride finished formulations upon request. The Besifloxacin Hydrochloride suppliers may include Besifloxacin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Besifloxacin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Besifloxacin Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Besifloxacin Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Besifloxacin Hydrochloride DMFs exist exist since differing nations have different regulations, such as Besifloxacin Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Besifloxacin Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Besifloxacin Hydrochloride USDMF includes data on Besifloxacin Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Besifloxacin Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Besifloxacin Hydrochloride suppliers with USDMF on PharmaCompass.
A Besifloxacin Hydrochloride written confirmation (Besifloxacin Hydrochloride WC) is an official document issued by a regulatory agency to a Besifloxacin Hydrochloride manufacturer, verifying that the manufacturing facility of a Besifloxacin Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Besifloxacin Hydrochloride APIs or Besifloxacin Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Besifloxacin Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Besifloxacin Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Besifloxacin Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Besifloxacin Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Besifloxacin Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Besifloxacin Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Besifloxacin Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Besifloxacin Hydrochloride suppliers with NDC on PharmaCompass.
Besifloxacin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Besifloxacin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Besifloxacin Hydrochloride GMP manufacturer or Besifloxacin Hydrochloride GMP API supplier for your needs.
A Besifloxacin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Besifloxacin Hydrochloride's compliance with Besifloxacin Hydrochloride specifications and serves as a tool for batch-level quality control.
Besifloxacin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Besifloxacin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Besifloxacin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Besifloxacin Hydrochloride EP), Besifloxacin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Besifloxacin Hydrochloride USP).
LOOKING FOR A SUPPLIER?